Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Castle Biosciences Inc (NQ: CSTL )

59.23 +3.39 (+6.07%)
Streaming Delayed Price Updated: 3:23 PM EDT, May 18, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 319,504
Open 56.47
Bid (Size) 59.14 (2)
Ask (Size) 59.32 (3)
Prev. Close 55.84
Today's Range 55.09 - 60.22
52wk Range 34.72 - 107.69
Shares Outstanding 25,056,411
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Tiffany Olson, Seasoned Diagnostics Executive, Joins Castle Biosciences’ Board of Directors
Castle today announced that Tiffany Olson has been appointed to its board of directors, effective immediately. 
From Business Wire News Releases
Castle Biosciences Recognized for Skin Cancer Diagnostics Innovation in 2021 MedTech Breakthrough Awards Program
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies 
From PR Newswire

Performance

YTD
-14.01%
-14.01%
1 Month
-9.59%
-9.59%
3 Month
-36.48%
-36.48%
6 Month
+17.87%
+17.87%
1 Year
+66.14%
+66.14%

More News

Read More
Castle Biosciences Announces First Quarter 2021 Results
From Business Wire News Releases
Castle Biosciences Announces Pipeline Initiative to Develop Genomic Test Targeting Systemic Therapy Response in Patients with Psoriasis, Atopic Dermatitis and Related Conditions
From Business Wire News Releases
Castle Biosciences Recognized for Skin Cancer Diagnostics Innovation in 2021 MedTech Breakthrough Awards Program
From Business Wire News Releases
New Data Demonstrate that 99% of Surveyed Patients Diagnosed With Uveal Melanoma Gain Value From DecisionDx-UM Test
From Business Wire News Releases
Castle Biosciences Collaborates With the Colorado Melanoma Foundation and Epiphany Dermatology to Provide Free Skin Cancer Screenings Across the Southwest U.S.
From Business Wire News Releases
Castle Biosciences Supports American Academy of Dermatology's "Skin Cancer, Take a Hike!™" Steps Challenge for Skin Cancer Awareness Month
From Business Wire News Releases
Castle Biosciences: Q1 Earnings Insights
Tags Market News Earnings CSTL
From Benzinga
Castle Biosciences Signs Definitive Agreement to Acquire Myriad myPath® Laboratory
From Business Wire News Releases
Castle Biosciences to Release First Quarter 2021 Financial Results, Provide Pipeline Update and Host Conference Call on Monday, May 10, 2021
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.